Form 4 for MDT Medtronic

Accepted 2022-08-03 00:00:00 ET · period of report 2022-08-01 · accession 0001127602-22-020417 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-08-03	2022-08-01	MDT	Salmon Sean	EVP, Pres Cardiovascular	A - Grant	$0.00	+8,595	36.2K	+31%	$0
DM	2022-08-03	2022-08-01	MDT	Salmon Sean	EVP, Pres Cardiovascular	A - Grant	$0.00	+89.4K	67.9K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2022-08-01	A	A	8,595	$0.00	36,214	D	—	—	(F1) The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
2	Derivative	Performance Share Units	2022-08-01	A	A	21,487	$0.00	21,487	D	— · — to —	21,487 Performance Share Units	(F3) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,487 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F2) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F4) Vests on August 1, 2025.
3	Derivative	Stock Option (Right to Buy)	2022-08-01	A	A	67,924	$0.00	67,924	D	$93.08 · — to 2032-08-01	67,924 Ordinary Shares	(F5) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.